Colinz Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

2.52

2.52

2.52

3.55

3.55

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

6.96

6.43

5.62

4.14

3.75

Loan funds

Secured loans

0.64

0.57

0.27

0.48

0.99

Unsecured loans

-

-

-

-

-

Total

10.12

9.52

8.41

8.17

8.28

Uses of funds

Fixed assets

Gross block

6.43

6.17

6.17

6.91

6.88

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

4.73

4.60

4.46

5.05

4.85

Net block

1.70

1.58

1.71

1.86

2.03

Capital work-in-progress

-

-

-

-

-

Investments

1.04

1.02

0.66

0.67

0.61

Net current assets

Current assets, loans & advances

9.07

8.76

7.86

7.40

7.46

Less : current liabilities & provisions

1.70

1.84

1.82

1.76

1.81

Total net current assets

7.37

6.92

6.04

5.64

5.65

Miscellaneous expenses not written

-

-

-

-

-

Total

10.12

9.52

8.41

8.17

8.28

Notes:

Book value of unquoted investments

1.04

1.02

0.66

0.67

0.61

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

0.35

0.09

0.28

24,367.23

0.25

Number of equity sharesoutstanding (Lacs)

25.19

25.19

25.19

35.45

35.45